Reduction in bone formation and elevated bone resorption in ovariectomized rats with special reference to acute inflammation - PubMed (original) (raw)
Reduction in bone formation and elevated bone resorption in ovariectomized rats with special reference to acute inflammation
T Tanizawa et al. Bone. 2000 Jan.
Abstract
Changes in bone modeling and remodeling in the tibia of growing rats within 30 days of ovariectomy (ovx) were evaluated by histomorphometric, mechanical; and biochemical means. Three days after ovx, suppressed bone formation was seen. This was shown by reduced osteoid volume, osteoblast surface, and bone formation rate in the secondary spongiosa, and a reduced longitudinal growth rate in the growth plate. In addition, the alkaline phosphatase and tartrate-resistant acid phosphatase activity in bone marrow supernatants was suppressed in conjunction with elevated serum sialic acid levels, indicating inflammation. Although estrogen deprivation itself may provoke the inflammatory process, the serum sialic acid level in the ovx group returned to the baseline level within 5 days after surgery, while that of estradiol in the ovx group remained consistently lower. This suggests that surgical stress, not estrogen deprivation, is the primary cause of the inflammatory response shortly after ovx. A significant difference (p < 0.01) between the ovx and sham rats was seen in the osteoclast surface, which peaked on day 7 in the ovx rats. On day 14 postovariectomy, the bone formation rate peaked and remained constant until day 30. In the ovx rats, there was a sustained reduction in the serum albumin level until day 30. Estrogen deprivation may be the primary cause of these changes, because both surgical ovx and medical oophorectomy with gonadotropin-releasing hormone agonist (G(nRHa) reduce the serum albumin level. In numerous studies dealing with changes after ovx in rats, we have observed: 1) a transient reduction in bone formation in relation to inflammatory changes evoked by ovx surgery, and 2) a sustained reduction in the serum albumin level for at least 30 days after ovx that is possibly due to estrogen deprivation.
Similar articles
- Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
Ke HZ, Chen HK, Qi H, Pirie CM, Simmons HA, Ma YF, Jee WS, Thompson DD. Ke HZ, et al. Bone. 1995 Nov;17(5):491-6. doi: 10.1016/8756-3282(95)00346-2. Bone. 1995. PMID: 8579962 - Increased bone resorption precedes increased bone formation in the ovariectomized rat.
Sims NA, Morris HA, Moore RJ, Durbridge TC. Sims NA, et al. Calcif Tissue Int. 1996 Aug;59(2):121-7. doi: 10.1007/s002239900098. Calcif Tissue Int. 1996. PMID: 8687981 - Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation.
Oxlund H, Andreassen TT. Oxlund H, et al. Bone. 2004 Apr;34(4):609-18. doi: 10.1016/j.bone.2003.12.014. Bone. 2004. PMID: 15050891 - A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ, Bu SY, Wang Y, Rendina E, Lim YF, Marlow D, Clarke SL, Cullen DM, Lucas EA. Smith BJ, et al. Bone. 2014 Jan;58:151-9. doi: 10.1016/j.bone.2013.10.005. Epub 2013 Oct 11. Bone. 2014. PMID: 24125756 - Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation.
Li B, Yu S. Li B, et al. Biol Pharm Bull. 2003 Jun;26(6):780-6. doi: 10.1248/bpb.26.780. Biol Pharm Bull. 2003. PMID: 12808286
Cited by
- Evaluation of Preventive Role of Systemically Applied Erythropoietin after Tooth Extraction in a Bisphosphonate-Induced MRONJ Model.
Duygu G, Yalcin-Ülker GM, Günbatan M, Soluk-Tekkesin M, Özcakir-Tomruk C. Duygu G, et al. Medicina (Kaunas). 2023 May 31;59(6):1059. doi: 10.3390/medicina59061059. Medicina (Kaunas). 2023. PMID: 37374263 Free PMC article. - Increased Ca2+ signaling through CaV1.2 promotes bone formation and prevents estrogen deficiency-induced bone loss.
Cao C, Ren Y, Barnett AS, Mirando AJ, Rouse D, Mun SH, Park-Min KH, McNulty AL, Guilak F, Karner CM, Hilton MJ, Pitt GS. Cao C, et al. JCI Insight. 2017 Nov 16;2(22):e95512. doi: 10.1172/jci.insight.95512. eCollection 2017 Nov 16. JCI Insight. 2017. PMID: 29202453 Free PMC article. - Administration frequency as well as dosage of PTH are associated with development of cortical porosity in ovariectomized rats.
Takakura A, Lee JW, Hirano K, Isogai Y, Ishizuya T, Takao-Kawabata R, Iimura T. Takakura A, et al. Bone Res. 2017 Apr 25;5:17002. doi: 10.1038/boneres.2017.2. eCollection 2017. Bone Res. 2017. PMID: 28503340 Free PMC article. - The Role of Bone Marrow Microenvironment in Governing the Balance between Osteoblastogenesis and Adipogenesis.
Li J, Liu X, Zuo B, Zhang L. Li J, et al. Aging Dis. 2015 Dec 6;7(4):514-25. doi: 10.14336/AD.2015.1206. eCollection 2016 Aug. Aging Dis. 2015. PMID: 27493836 Free PMC article. Review. - A Liver-Bone Endocrine Relay by IGFBP1 Promotes Osteoclastogenesis and Mediates FGF21-Induced Bone Resorption.
Wang X, Wei W, Krzeszinski JY, Wang Y, Wan Y. Wang X, et al. Cell Metab. 2015 Nov 3;22(5):811-24. doi: 10.1016/j.cmet.2015.09.010. Epub 2015 Oct 8. Cell Metab. 2015. PMID: 26456333 Free PMC article.